Journal Article

DZNE-2025-00899

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Neurofilament light chain reference values in serum and cerebrospinal fluid: a bi-compartmental analysis in neurological diseases.

Halbgebauer, S. (First author)DZNE* ; Klose, V.DZNE* ; Fazeli, B. ; Klassen, P. C.DZNE* ; Alexudis, C.Extern* ; Nagel, G. ; Rosenbohm, A. ; Rothenbacher, D. ; Gomez de San Jose, N. ; Witzel, S. ; Elmas, Z. ; Wiesenfarth, M. ; Schuster, J.Extern* ; Dorst, J.Extern* ; Huss, A. ; Bachhuber, F. ; Otto, M. ; Landwehrmeyer, G. B.Extern* ; Ludolph, A. C.DZNE* ; Tumani, H.Extern*

2025
Steinkopff [Darmstadt]

This record in other databases:  

Please use a persistent id in citations: doi:10.1007/s00415-025-13271-1

Abstract: Concentrations of neurofilament light chain (NfL), a neuroaxonal damage marker, increase with age. Therefore, age-dependent reference values are important in clinical practice. However, so far these have only been established with a bead-based system and age-dependent z-scores for CSF are missing. In addition, we here propose how the combined analysis of CSF and serum NfL could help in the discrimination between central (CNS) and peripheral nervous system (PNS) axonal degeneration.For the calculation of age reference values, serum and CSF NfL concentrations from 1,514 control subjects, measured using the microfluidic Ella system, were applied.Age-dependent NfL levels were calculated with additive quantile regression and presented with percentiles and z-scores. We observed a non-linear increase of NfL in serum and CSF. The spearman r of the association with age was 0.81 (95% CI 0.78-0.83), p < 0.0001 and 0.82 (95% CI 0.79-0.85), p < 0.0001 for serum and CSF NfL, respectively. Serum and CSF NfL levels were also associated with each other (r = 0.68 (95%CI 0.62-0.73), p < 0.0001). Furthermore, we used this association to establish a bi-compartmental CSF and serum NfL model allowing to differentiate between peripheral or central origin of neurodegeneration.The age reference curves corroborate findings of an exponential elevation of NfL in serum and CSF with increasing age. As NfL values from different platforms are not interchangeable, this is of additional high relevance. Moreover, the association between CSF and serum NfL values could be applied for clinical use regarding overlapping symptoms of CNS and PNS-based neurological diseases.

Keyword(s): Humans (MeSH) ; Neurofilament Proteins: blood (MeSH) ; Neurofilament Proteins: cerebrospinal fluid (MeSH) ; Male (MeSH) ; Female (MeSH) ; Middle Aged (MeSH) ; Adult (MeSH) ; Aged (MeSH) ; Reference Values (MeSH) ; Young Adult (MeSH) ; Nervous System Diseases: blood (MeSH) ; Nervous System Diseases: cerebrospinal fluid (MeSH) ; Nervous System Diseases: diagnosis (MeSH) ; Adolescent (MeSH) ; Aged, 80 and over (MeSH) ; Child (MeSH) ; Biomarkers: blood (MeSH) ; Biomarkers: cerebrospinal fluid (MeSH) ; Child, Preschool (MeSH) ; Aging: blood (MeSH) ; Aging: cerebrospinal fluid (MeSH) ; Age reference values ; Bi-compartment model ; CSF ; Neurofilament ; NfL ; Serum ; Z-score ; Neurofilament Proteins ; neurofilament protein L ; Biomarkers

---

Contributing Institute(s):

1. Clinical Study Center (Ulm) (Clinical Study Center (Ulm))
2. Neuroepidemiology (AG Zhan)

Research Program(s):

1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)
2. 354 - Disease Prevention and Healthy Aging (POF4-354) (POF4-354)

Appears in the scientific report 2025

---

Database coverage:
; ; ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Springer ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; JCR ; Nationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---